“Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies”. 2020. SKIN The Journal of Cutaneous Medicine 4 (5): s63. https://doi.org/10.25251/skin.4.supp.62.